Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eporon vs Eprex in Anemia of Chronic Renal Failure
NCT03521713Phase 3Unknown
- Sponsor
- Dong-A ST
- Start
- Mar 2016
- Primary completion
- Sep 2020
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Dong-A ST. Status: unknown.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03521713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03521713.